Literature DB >> 22234600

FP-CIT SPECT evaluation: time to go beyond visual assessment!

A Skanjeti, T Angusti, M Margheron, M Iudicello, V Podio.   

Abstract

Mesh：

Year:  2012        PMID： 22234600     DOI： 10.1007/s00259-011-2042-3

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  4 in total

Review 1.  SPECT imaging evaluation in movement disorders: far beyond visual assessment.

Authors:  Kosmas Badiavas; Elisavet Molyvda; Ioannis Iakovou; Magdalini Tsolaki; Kyriakos Psarrakos; Nikolaos Karatzas
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-12-02       Impact factor: 9.236

2.  The cost effectiveness of 123I-FP-CIT SPECT imaging in patients with an uncertain clinical diagnosis of parkinsonism.

Authors:  Koen Van Laere; Ludwig Everaert; Lieven Annemans; Michel Gonce; Wim Vandenberghe; Thierry Vander Borght
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-04-02       Impact factor: 9.236

3.  Cost-effectiveness of 123I-FP-CIT SPECT in the differential diagnosis of essential tremor and Parkinson's disease in Italy.

Authors:  Angelo Antonini; Patrizia Berto; Stefania Lopatriello; Filippo Tamma; Lieven Annemans; Mike Chambers
Journal:  Mov Disord       Date:  2008-11-15       Impact factor: 10.338

4.  Meta-analysis of the literature on diagnostic accuracy of SPECT in parkinsonian syndromes.

Authors:  Annemarie M M Vlaar; Marinus J P G van Kroonenburgh; Alfons G H Kessels; Wim E J Weber
Journal:  BMC Neurol       Date:  2007-09-01       Impact factor: 2.474
  4 in total
  1 in total

1.  Establishing On-Site Reference Values for (123)I-FP-CIT SPECT (DaTSCAN®) Using a Cohort of Individuals with Non-Degenerative Conditions.

Authors:  Nicolas Nicastro; Valentina Garibotto; Antoine Poncet; Simon Badoud; Pierre R Burkhard
Journal:  Mol Imaging Biol       Date:  2016-04       Impact factor: 3.488
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.